Global Mantle Cell Lymphoma Therapeutics Market 2019-2023
- Published: Jul 2019
- Pages: 131
- SKU: IRTNTR31758
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The global mantle cell lymphoma therapeutics market size will grow by USD 1.35 billion during 2019-2023. This market report provides a detailed analysis of the market by product (combination therapy and monotherapy) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on many market vendors, including Allergan Plc, AstraZeneca Plc, Celgene Corp., Johnson & Johnson Services Inc., and Takeda Pharmaceutical Co. Ltd.
Some of the key findings from our mantle cell lymphoma therapeutics market forecast report are summarized below
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Global Mantle Cell Lymphoma Therapeutics Industry Overview
Until the last decade, there were no approved therapeutics to treat mantle cell lymphoma because it is a rare disease. The significant unmet need for the treatment of the condition gave immense growth opportunities to the vendors of the global mantle cell lymphoma market. The vendors have been focusing on the development of reliable therapeutics to treat various blood carcinomas, including mantle cell lymphoma. As a result, several therapeutics were approved in the last few years, increasing the sales of vendors. Therefore, recent approvals of drugs will significantly drive the mantle cell lymphoma therapeutics market growth at a CAGR of over 7% during the forecast period.
The strong prevalence of various types of blood cancer has increased the need for the development of advanced therapies such as kinase inhibitors and gene therapies. Therefore, vendors are increasingly collaborating and testing therapeutics to treat types of blood cancer. The success of efficacy of certain therapeutics on various types of blood cancer has increased the scope of improvement of therapeutics to treat mantle cell lymphoma. For instance, Merck, in collaboration with Icahn School of Medicine at Mount Sinai, is testing pembrolizumab at Phase I/II stage of development for the treatment of mantle cell lymphoma. These factors indicate that the launch of various novel therapies has increased. Therefore, the advent of novel therapies is one of the key mantle cell lymphoma therapeutics market trends. The trend will contribute to market growth during the forecast period.
Top Mantle Cell Lymphoma Therapeutics Companies Covered in this Market Research Report
The global mantle cell lymphoma therapeutics market is concentrated. To help clients improve their market positions, this report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. This mantle cell lymphoma therapeutics market research report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the upcoming growth opportunities.
The report offers a detailed analysis of several leading mantle cell lymphoma therapeutics manufacturers, including:
- Allergan Plc
- AstraZeneca Plc
- Celgene Corp.
- Johnson & Johnson Services Inc.
- Takeda Pharmaceutical Co. Ltd.
Mantle Cell Lymphoma Therapeutics Market Segmentation Based on Product
- Combination therapy
- Monotherapy
The combination therapy segment held the largest market share in 2018. It will account for the highest global mantle cell lymphoma therapeutics market share over the forecast period. Advantages of combination therapy over monotherapy, reduced drug resistance, and rising development and commercialization of combination therapies are expected to promote the growth of the market segment in the forthcoming years. This report provides an accurate prediction of the contribution of all the segments to the growth of the mantle cell lymphoma therapeutics market size.
Mantle Cell Lymphoma Therapeutics Market Segmentation Based on Geographic Region
- Asia
- Europe
- North America
- ROW
With a complete study of the growth opportunities for the companies, it has been identified that North America will account for the highest share of the mantle cell lymphoma therapeutics market throughout the forecast period. Factors such as the high sales of approved drugs for the treatment of mantle cell lymphoma and increasing prevalence of various hematologic cancer types are contributing to the mantle cell lymphoma therapeutics market growth in this region.
Key Highlights of the Global Mantle Cell Lymphoma Therapeutics Market for the Forecast Years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the mantle cell lymphoma therapeutics market during the next five years
- precise estimation of the global mantle cell lymphoma therapeutics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the mantle cell lymphoma therapeutics industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details of factors that will challenge the growth of mantle cell lymphoma therapeutics companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Combination therapy - Market size and forecast 2018-2023
- Monotherapy - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Advent of novel therapies
- Research grants and funding
- Special drug designations
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Allergan Plc
- AstraZeneca Plc
- Celgene Corp.
- Johnson & Johnson Services Inc.
- Takeda Pharmaceutical Co. Ltd.
PART 14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
